The global ocular implants market size is expected to reach USD 22.09 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 5.8% from 2025 to 2030. Increasing focus on the development of technologically advanced products is expected to drive the market. Additionally, the growing incidence of eye disorders such as glaucoma, cataract, and age-related macular degeneration is predicted to propel the demand for ocular implants. According to the World Glaucoma Association, an estimated 79.6 million individuals were anticipated to have glaucoma in 2020.
Due to the imposition of multiple lockdown restrictions, travel restrictions, and complete lockdowns in many countries, the economies worldwide have observed a major loss moving it into a state of recession. The COVID-19 impact was also strongly felt across the healthcare systems. While certain markets witnessed a major rise in demand due to the need for ocular implants in diagnoses and the treatment of COVID-19, certain other products observed a sharp fall in sales, especially during the peak of the pandemic. The market belonged to the latter and witnessed a negative impact due to the outbreak of COVID-19. The cancellation and postponement of elective surgeries in order to avoid the transmission of the virus to the staff and patients led to a fall in the sales of ocular implants in 2020.
However, the introduction of vaccines and specific strategies based on earlier experience to curtail the similar impact of the third or fourth wave in most countries is helping the market to regain its growth. Additionally, the outbreak of COVID-19 has created a higher preference among patients to visit specialty eye institutes rather than hospitals in order to avoid crowded places that pose a higher threat of contracting the virus, thereby increasing the demand for specialty clinics. Moreover, the new dynamics involved in the occupation and education system have increased the overall screen-time of individuals, which is expected to contribute to the rising incidence of eye diseases. This, in turn, is expected to enhance the market growth during the forecast period.
Request a free sample copy or view report summary: Ocular Implants Market Report
The glaucoma implants product segment dominated the market in 2024 owing to the growing incidence of glaucoma globally
The glaucoma surgery application held the largest revenue share in 2024 and this trend is expected to continue during the forecast period
By end use, the hospitals segment dominated the market with a revenue share of more than 42.29% in 2024 due to the increasing number of hospital admissions across the globe
The specialty eye institutes end-use segment is expected to witness significant growth during the forecast period owing to the rising need for eye care services in remote areas
Grand View Research has segmented the global ocular implants market based on product, application, end use, and region:
Ocular Implants Product Outlook (Revenue, USD Million, 2018 - 2030)
Intraocular Lens
Corneal Implants
Orbital Implants
Glaucoma Implants
Ocular Prosthesis
Others
Ocular Implants Application Outlook (Revenue, USD Million, 2018 - 2030)
Glaucoma Surgery
Oculoplasty
Drug Delivery
Age related Macular Degeneration
Aesthetic Purpose
Ocular Implants End Use Outlook (Revenue, USD Million, 2018 - 2030)
Hospitals
Specialty Eye institutes
Clinics
Ocular Implants Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Australia
South Korea
Thailand
Latin America
Brazil
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players of Ocular Implants Market
Alcon, Inc.
Bausch + Lomb.
Carl Zeiss AG
Johnson & Johnson Services, Inc.
STAAR SURGICAL
MORCHER GmbH
Glaukos Corporation.
"The quality of research they have done for us has been excellent..."